Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction
CA 2784829 C · Owner: University Of Utah Research Foundation · Inventors: Westenfelder, Christof
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods for the treatment of acute renal failure multi-organ failure, early dysfunction of kidney transplant chronic renal failure, organ dysfunction and wound healing are provided. The methods include delivering a therapeutic amount of hematopoietic stem cells non--hematopoietic, mesenchymal stem cells hemangioblasts, and pre--differentiated cells to a patient in need thereof.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 31, 2004 and granted October 6, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 31, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 31, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.